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Bone regeneration is the physiological process of bone for-
mation that occurs during normal fracture healing, and is in-
volved in continuous remodelling throughout adult life.
However, there are complex clinical conditions in which ex-
tensive bone regeneration is needed, for example, in cases
of osteoporosis (Dimitriou et al., 2011).
Bone grafting is one of the most commonly used surgical
methods to augment bone in orthopaedic procedures. Bioce-
ramic materials have enormous potential for natural bone
tissue repair (Wang et al., 2017). Calcium phosphates bone
grafts are among the best-known and clinically established
means of bone repair. This material provides bone with the
following characteristics: osteoconductivity, biocompatibil-
ity and biodegradation (Carsten et al., 2015). Biphasic cal-
cium phosphate ceramic as a bone replacement material is
used to improve the properties of osteoporotic bones and
promote bone tissue healing. Calcium hydroxyapatite is
highly bioaccumulative and forms a direct bond with bone
tissue. Tricalcium phosphate acts as a catalyst for stimulat-
ing the formation of new bone tissue (Ratner et al., 2013).
Strontium-releasing calcium phosphate bone cements are
prospective materials for the clinical regeneration of osteo-
porosis-related bone defects, because they stimulates bone
formation and at the same time limit osteoclastic bone re-
sorption (Lode et al., 2017).
Previous studies have investigated the effect of biomaterials
on bone regeneration in the site of implantation. The aim of
the present study was to determine how local addition of
biphasic calcium phosphate materials in the femur tro-
chanter area affects bones mineral density outside the im-
plantation zone in vivo. We examined rabbit femur after
ovariectomy and subsequent implantation of calcium hy-
droxyapatite with tricalcium phosphate in proportion 70/30,
without or with 5% strontium; in comparison to non-
operated and sham surgery legs as controls.
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Bone density of the femur body of rabbit was determined in vivo. Experimental osteoporosis was
induced by ovariectomy and subsequent injections of methylprednisolone. In the greater tro-
chanter region of right femur, defects were created and filled with granules of hydroxyapatite and
tricalcium phosphate (HAP/TCP 70/30) or HAP/TCP 70/30 together with 5% strontium. After three
months, the animals were euthanized. The bone mass density of the right and left body of femur
was measured by cone beam computed tomography (CT) scan. The results of the study showed
that the right femur of the rabbit, where biomaterials had been implanted, and the left femur,
where no biomaterial implantation occurred, became denser after filling the defect with HAP/TCP
70/30 ceramic granules or 5% Sr modified HAP/TCP ceramic granules. There was no difference
between operated and non-operated legs and HAP/TCP and HAP/TCP with 5% strontium groups.
Key words: bone density, osteoporosis, biphasic calcium phosphate, in vivo, strontium.
S h o r t C o m m u n i c a t i o n
185Proc. Latvian Acad. Sci., Section B, Vol. 73 (2019), No. 2.
Experimental osteoporosis was induced in 19 eight-month
old female rabbits after ovariectomy followed by 1 mg/kg
daily methylprednisolone injection. The duration of the
treatment was six weeks. Defects were created in the right
femur greater trochanter region in 15 rabbits. Femur of
seven animals were filled with biphasic ceramics
(HAP/TCP 70/30), and the remaining eight were filled with
5% Sr modified biphasic ceramics. The sham surgery group
consisted of four female rabbits with similar bone defects,
but without implantation of biomaterials. After three
months, the animals were euthanized (Fig. 1). Permission of
the study was received by the Animal Ethics Committee of
Food and Veterinary Administration of Latvia.
The bone mass density of the right (operated) and left
(non-operated) femur body was measured by cone beam CT
scan using iCAT Next Generation (KAVO, Germany) in
Rîga Stradiòð University, Institute of Stomatology, Depart-
ment of Oral and Maxillofacial Diagnostic Radiology. The
hardware was used with a standard operating protocol (volt-
age 120 KV, current strength 38 mA, test field (FOV) 17
cm, resolution 0.4 units).
The obtained test data were processed and analysed using
hardware-specific software iCAT eXamVision (Kavo, Ger-
many). The voxel value of suppression of the image in the
femur body was determined. The values, which were dis-
played in Hawsfield units (HU), were converted to 1 : 1 val-
ues of radiological suppression in units (Do-Gyoon Kim,
2014). Determination of the image blackout value was done
in a 4 mm2 field (Fig. 2).
Statistical data analysis, calculation and all graphs were
made using software GraphPad PRISM version 6.0e
(GraphPad Software Inc., San Diego, California, USA).
Unequal SD comparison of medians between different
groups was performed with the Mann–Whitney test. All
biomechanical parameters were presented as medians (Md)
with interquartile range (IQR). Two values were considered
as statistically significantly different if the p-value was less
than 0.05 (p < 0.05).
The test samples were divided into three treatment groups:
sham surgery treatment (group A), HAP/TCP treatment
(group B) and HAP/TCP with 5% Sr treatment (group C).
The results of the study showed that in the sham surgery
group, bone density in the right (operated) and the left
(non-operated) body of the femur was less than in the other
two groups.
The bone density in the operated body of the femur in group
A was 923 HU (range 1056–843.5), which was statistically
significantly lower (p = 0.016) than in group B (1302 HU,
range 1350–1209) and C group (1344 HU, range 1459–
1156), p = 0.042. Statistically significant differences be-
tween groups B and C were not found (p = 0.761) (Fig. 3).
The density of non-operated body of the femur bone in
group A was 935.5 HU (range 1053–876), which was sig-
Fig. 1. A scheme of the rabbit treatment
groups.
Fig. 2. Cone beam CT scan image for determi-
nation of suppression level ion the femur
body – sagittal plane view. Red lines – coronal
plane view, blue lines – axial plane view.
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nificantly less (p = 0.016) than in group B (1212 HU, range
1360–1138) and in C group (1261 HU, range 1315–1090),
p = 0.012. Statistically significant differences between
groups B and C were not found (p = 0.99). (Fig. 4).
Biphasic calcium phosphate (BCP) ceramic can be used as
bone grafting material to strengthen osteoporotic bone and
to improve bone healing. BCP materials have high bioactiv-
ity. It is supposed that TCP, which has a minor amount of in
the composition, has a relatively faster resorption rate com-
pared to HAP and will ensure the initial burst of release of
calcium and orthophosphate ions into the blood vessels,
thus seeding new bone formation (Salma et al., 2015). In
our study there were no statistically significant differences
in bone density between operated and non-operated legs.
The major calcium phosphate biomaterials are not homoge-
nous and contain trace elements that have been found to
play a vital function in growth and bone repair (Ehret et al.,
2017). In vitro and in vivo studies have indicated that stron-
tium increases bone formation and reduces bone resorption
(Landi et al., 2007). The dual effects of strontium to in-
crease bone formation and inhibit bone resorption have
been widely reported. Strontium doped in calcium phos-
phate still showed a positive effect on osteoblasts and had
an inhibitory effect on osteoclasts in in vitro experiments.
(Li et al., 2015). Since strontium acts as a dual agent, the
optimal amount of strontium remains a subject of investiga-
tion. As described in the literature, the levels of strontium in
bioceramics vary from 1% to 100% (Ehret et al., 2017). At
low concentrations, strontium administration was shown to
reduce bone resorption and stimulate bone formation (Jegou
Saint-Jean et al., 2005). In our study biphasic ceramic gran-
ules enriched with 5% strontium showed the same results
than HAP/TCP alone.
The study found that the right femur of the rabbit, where the
biomaterial is implanted, became denser after filling the de-
fects with HAP/TCP 70/30 ceramic granules or 5% Sr
modified HAP/TCP ceramic granules, compared to the left
femur in which no biomaterial implantation was performed.
There were no significant differences in bone density be-
tween operated and non-operated legs. There were also no
significant differences between treatments with HAP/TCP
and HAP/TCP with 5% strontium groups. It might be possi-
ble to achieve better results with strontium in greater
concentration. Further studies are needed with different
amounts of strontium in order to better understand its role
in bone repair mechanisms.
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BIFÂZISKA KALCIJA FOSTÂTA VISPÂRÇJÂ IETEKME UZ OSTEOPOROTISKU KAULU MINERÂLBLÎVUMU
Tika veikta labâs un kreisâs kâjas augðstilba íermeòa daïas kaula blîvuma mçrîðana truðiem ar eksperimentâlo osteoporozi, izmantojot
konisku stara datortomogrâfiju palîdzîbu (iCAT Next Generation, KAVO, Vâcija). Iegûtie izmeklçjumu dati tika apstrâdâti un analizçti,
izmantojot aparatûrai atbilstoðo programmatûru iCAT eXamVision (Kavo, Vâcija). Eksperimentâlâ osteoporoze tika izraisîta astoòus
mçneðus veciem sieviðíâ dzimuma truðiem pçc ovarektomijas un tai sekojoðas 1 mg/kg dienâ metilprednozolona injekcijas. Terapijas
ilgums bija seðas nedçïas. Truðiem tika izveidoti defekti labâs kâjas augðstilba trochanter majus rajonâ. Defekti tika aizpildîti ar bifâzisku
keramiku (HAP/TCP 70/30) vai 5% Sr modificçtu divfâþu keramiku. Placebo íirurìijas grupai tika izveidots identisks kaula defekts, bet
netika implantçta biokeramika. Pçc trim mçneðiem dzîvniekiem tika veikta eitanâzija. Pçtîjumâ tika konstatçts, ka truðu labâs kâjas
augðstilba kauls, kur tika veikta biomateriâla implantâcija, un kreisâs kâjas augðstilba kauls, kur netika veikta biomateriâla implantâcija,
kïuva blîvâks pçc defekta aizpildîðanas ar HAP/TCP 70/30 keramikas granulâm vai ar 5% Sr modificçtas HAP/TCP keramikas granulâm.
Statistiski ticamas atðíirîbas starp HAP/TCP un ar 5% Sr modificçtu divfâþu keramiku grupâm, operçtu un neoperçtu augðstilbu netika
atrastas.
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